Effect of immune checkpoint inhibitors at different treatment time periods on prognosis of patients with extensive-stage small-cell lung cancer
Article in Clinical and Translational Oncology (April 2024)
The most recent citing publications are shown below. View all 6 publications that cite this research output on Dimensions.
Real-world evaluation of first-line treatment of extensive-stage small-cell lung cancer with atezolizumab plus platinum/etoposide: a focus on patients with brain metastasis
Article in Clinical and Translational Oncology (February 2024)
Continuation of immunotherapy beyond progression is beneficial to the survival of advanced non-small-cell lung cancer
Article in Clinical and Translational Oncology (December 2023)